Variant report

Variant	nsv978752
Chromosome Location	chr19:42082354-42093112
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:82)
CpG islands
(count:305)
Chromatin interactive
region (count:3)
LncRNA
region (count:7)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:82 , 50 per page) page: 1 2

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	CBX3	chr19:42087500-42087699	K562	blood:	n/a	n/a
2	CBX3	chr19:42089010-42089278	K562	blood:	n/a	n/a
3	CBX3	chr19:42088705-42088947	K562	blood:	n/a	n/a
4	CEBPB	chr19:42090185-42090207	K562	blood:	n/a	n/a
5	CEBPB	chr19:42083432-42083775	HepG2	liver:	n/a	chr19:42083597-42083608
6	CEBPB	chr19:42090058-42090357	HepG2	liver:	n/a	chr19:42090204-42090215
7	CEBPB	chr19:42090057-42090363	A549	lung:	n/a	chr19:42090204-42090215
8	CEBPB	chr19:42089327-42089439	IMR90	lung:	n/a	n/a
9	CEBPB	chr19:42089247-42089343	A549	lung:	n/a	n/a
10	CEBPB	chr19:42090040-42090299	IMR90	lung:	n/a	chr19:42090204-42090215
11	CEBPB	chr19:42089226-42089355	K562	blood:	n/a	n/a
12	CTCF	chr19:42085140-42085290	HFF-Myc	foreskin:	n/a	n/a
13	CTCF	chr19:42082361-42082630	Spleen_OC	spleen:	n/a	n/a
14	CTCF	chr19:42090500-42090650	GM12865	blood:	n/a	n/a
15	ELF1	chr19:42082323-42082648	K562	blood:	n/a	chr19:42082482-42082493
16	ELF1	chr19:42082220-42082829	GM12878	blood:	n/a	chr19:42082482-42082493
17	ELK1	chr19:42082191-42082664	GM12878	blood:	n/a	n/a
18	GABPA	chr19:42082408-42082614	GM12878	blood:	n/a	n/a
19	GABPA	chr19:42082232-42082730	HL-60	blood:	n/a	n/a
20	JUND	chr19:42083576-42083760	HepG2	liver:	n/a	n/a
21	KAP1	chr19:42088794-42089334	HEK293	kidney:	n/a	n/a
22	KAP1	chr19:42088834-42089447	K562	blood:	n/a	n/a
23	KAP1	chr19:42087612-42087883	K562	blood:	n/a	n/a
24	MAZ	chr19:42082414-42082549	K562	blood:	n/a	n/a
25	MAZ	chr19:42082309-42082667	GM12878	blood:	n/a	n/a
26	MTA3	chr19:42082287-42082876	GM12878	blood:	n/a	n/a
27	PAX5	chr19:42082230-42082620	GM12878	blood:	n/a	n/a
28	PML	chr19:42082419-42082602	GM12878	blood:	n/a	n/a
29	POLR2A	chr19:42082444-42082638	MCF-7	breast:	n/a	n/a
30	POLR2A	chr19:42082380-42082684	GM12891	blood:	n/a	n/a
31	POLR2A	chr19:42082217-42082819	HL-60	blood:	n/a	n/a
32	POLR2A	chr19:42082215-42082757	GM12892	blood:	n/a	n/a
33	POLR2A	chr19:42082396-42082496	HUVEC	blood vessel:	n/a	n/a
34	POLR2A	chr19:42082278-42082370	HUVEC	blood vessel:	n/a	n/a
35	POLR2A	chr19:42083937-42084006	MCF-7	breast:	n/a	n/a
36	POLR2A	chr19:42082273-42082867	SK-N-MC	brain:	n/a	n/a
37	POLR2A	chr19:42082218-42082731	GM12878	blood:	n/a	n/a
38	POLR2A	chr19:42082284-42082756	HL-60	blood:	n/a	n/a
39	POLR2A	chr19:42082376-42082737	GM19193	blood:	n/a	n/a
40	POLR2A	chr19:42082302-42082757	GM12892	blood:	n/a	n/a
41	POLR2A	chr19:42082380-42082737	GM12892	blood:	n/a	n/a
42	POLR2A	chr19:42082402-42082646	MCF-7	breast:	n/a	n/a
43	POLR2A	chr19:42082373-42082747	GM12878	blood:	n/a	n/a
44	POLR2A	chr19:42082447-42082644	MCF-7	breast:	n/a	n/a
45	POLR2A	chr19:42083812-42083878	GM12878	blood:	n/a	n/a
46	POLR2A	chr19:42082225-42082833	GM12878	blood:	n/a	n/a
47	POLR2A	chr19:42082316-42082792	GM12892	blood:	n/a	n/a
48	POLR2A	chr19:42082363-42082751	GM12878	blood:	n/a	n/a
49	POLR2A	chr19:42082350-42082753	GM18505	blood:	n/a	n/a
50	POLR2A	chr19:42082355-42082738	GM12878	blood:	n/a	n/a

(count:305 , 50 per page) page: 1 2 3 4 5 6 7

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr19:42082350-42082400	H1-hESC	embryonic stem cell:	embryo
2	chr19:42082350-42082400	ECC-1	luminal epithelium:	n/a
3	chr19:42082350-42082400	SK-N-MC	brain:	n/a
4	chr19:42082350-42082400	GM12878	blood:	n/a
5	chr19:42083748-42083798	BE2_C	brain:	n/a
6	chr19:42093086-42093136	ovcar-3	ovarian:	n/a
7	chr19:42083748-42083798	SAEC	small airway:	n/a
8	chr19:42093086-42093136	HIPEpiC	eye:	n/a
9	chr19:42082570-42082620	HEK293	kidney:	embryo
10	chr19:42082570-42082620	AoSMC	blood vessel:	n/a
11	chr19:42093086-42093136	PrEC	prostate:	n/a
12	chr19:42093086-42093136	Jurkat	blood:	n/a
13	chr19:42082570-42082620	SK-N-SH_RA	brain:	n/a
14	chr19:42082350-42082400	HCF	heart:	n/a
15	chr19:42082570-42082620	HPAEpiC	pulmonary alveolar:	n/a
16	chr19:42082350-42082400	NT2-D1	testis:	n/a
17	chr19:42083748-42083798	MCF10A-Er-Src	breast:	n/a
18	chr19:42083748-42083798	T-47D	breast:	n/a
19	chr19:42093086-42093136	HRPEpiC	eye:	n/a
20	chr19:42082570-42082620	HRCEpiC	kidney:	n/a
21	chr19:42082485-42082535	HAEpiC	amniotic membrane:	n/a
22	chr19:42083748-42083798	H1-hESC	embryonic stem cell:	embryo
23	chr19:42082350-42082400	AG04449	skin:	fetal
24	chr19:42093086-42093136	CMK	blood:	n/a
25	chr19:42082350-42082400	HIPEpiC	eye:	n/a
26	chr19:42083748-42083798	HCT-116	colon:	n/a
27	chr19:42082485-42082535	PrEC	prostate:	n/a
28	chr19:42093086-42093136	HRE	kidney:	n/a
29	chr19:42093086-42093136	K562	blood:	n/a
30	chr19:42082570-42082620	RPTEC	kidney:	n/a
31	chr19:42083748-42083798	NB4	blood:	n/a
32	chr19:42082485-42082535	AG09309	skin:	n/a
33	chr19:42082485-42082535	A549	lung:	n/a
34	chr19:42083748-42083798	IMR90	lung:	fetal
35	chr19:42093086-42093136	ProgFib	skin:	n/a
36	chr19:42082570-42082620	HAEpiC	amniotic membrane:	n/a
37	chr19:42083748-42083798	HNPCEpiC	eye:	n/a
38	chr19:42093086-42093136	Caco-2	colon:	n/a
39	chr19:42083748-42083798	HRCEpiC	kidney:	n/a
40	chr19:42082570-42082620	GM06990	blood:	n/a
41	chr19:42082485-42082535	HPAEpiC	pulmonary alveolar:	n/a
42	chr19:42082485-42082535	CMK	blood:	n/a
43	chr19:42082570-42082620	K562	blood:	n/a
44	chr19:42093086-42093136	HRCEpiC	kidney:	n/a
45	chr19:42093086-42093136	GM12892	blood:	n/a
46	chr19:42082570-42082620	ECC-1	luminal epithelium:	n/a
47	chr19:42082485-42082535	AG04450	lung:	fetal
48	chr19:42093086-42093136	GM12878	blood:	n/a
49	chr19:42083748-42083798	K562	blood:	n/a
50	chr19:42082350-42082400	HUVEC	blood vessel:	n/a

(count:3 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr19:42090966..42093146-chr19:42106951..42108907,2	MCF-7	breast:
2	chr19:42078682..42081058-chr19:42082951..42085705,2	MCF-7	breast:
3	chr19:42077943..42079577-chr19:42084170..42086427,2	K562	blood:

(count:7 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-CEACAM21-1	chr19:42092817-42093197	NR_110107
2	lnc-CEACAM21-1	chr19:42085623-42085981	NR_110107
3	lnc-CEACAM21-1	chr19:42092193-42092224	NR_110107
4	lnc-CEACAM21-1	chr19:42091796-42091848	NR_110107
5	lnc-CEACAM21-1	chr19:42082531-42082690	NR_110107
6	lnc-CEACAM21-1	chr19:42090703-42090796	NR_110107
7	lnc-CEACAM21-1	chr19:42083552-42083911	NR_110107

No data

Variant related genes	Relation type
CEACAM21	TF binding region
CEACAM21	CpG island
ENSG00000239736	chromatin interactions

Extended variants
information (count: 478 )
Associated
traits (count: 64 )

Variant overlapped rSNPs/rCNVs (count:478 , 50 per page) page: 1 2 3 4 5 6 7 ... 10

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs111705471	chr19:42082425-42082426	Enhancers Flanking Active TSS Bivalent Enhancer Active TSS Bivalent/Poised TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
2	rs184847922	chr19:42082436-42082437	Enhancers Flanking Active TSS Bivalent Enhancer Active TSS Bivalent/Poised TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
3	rs372162857	chr19:42082444-42082445	Enhancers Flanking Active TSS Bivalent Enhancer Active TSS Bivalent/Poised TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
4	rs542854956	chr19:42082470-42082471	Enhancers Flanking Active TSS Bivalent Enhancer Active TSS Bivalent/Poised TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
5	rs373373082	chr19:42082473-42082474	Enhancers Flanking Active TSS Bivalent Enhancer Active TSS Bivalent/Poised TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
6	rs7257601	chr19:42082478-42082479	Enhancers Flanking Active TSS Bivalent Enhancer Active TSS Bivalent/Poised TSS	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
7	rs187573219	chr19:42082485-42082486	Enhancers Flanking Active TSS Bivalent Enhancer Active TSS Bivalent/Poised TSS	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
8	rs147772504	chr19:42082486-42082487	Enhancers Flanking Active TSS Bivalent Enhancer Active TSS Bivalent/Poised TSS	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
9	rs551535923	chr19:42082500-42082501	Enhancers Flanking Active TSS Bivalent Enhancer Active TSS Bivalent/Poised TSS	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
10	rs550863797	chr19:42082519-42082520	Enhancers Flanking Active TSS Bivalent Enhancer Active TSS Bivalent/Poised TSS	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
11	rs532388993	chr19:42082551-42082552	Enhancers Flanking Active TSS Bivalent Enhancer Active TSS Bivalent/Poised TSS	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
12	rs192912486	chr19:42082559-42082560	Enhancers Flanking Active TSS Bivalent Enhancer Active TSS Bivalent/Poised TSS	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
13	rs375614286	chr19:42082570-42082571	Enhancers Flanking Active TSS Bivalent Enhancer Active TSS Bivalent/Poised TSS	TF binding region CpG island lncRNA	1 gene(s)	Overlapped CNVs	n/a
14	rs62119452	chr19:42082616-42082617	Weak transcription Flanking Active TSS Enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS	lncRNA	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
15	rs536596299	chr19:42082626-42082627	Weak transcription Flanking Active TSS Enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
16	rs35227422	chr19:42082633-42082634	Weak transcription Flanking Active TSS Enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
17	rs200169591	chr19:42082647-42082648	Weak transcription Flanking Active TSS Enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
18	rs199766514	chr19:42082664-42082665	Weak transcription Flanking Active TSS Enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
19	rs371372590	chr19:42082670-42082671	Weak transcription Flanking Active TSS Enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
20	rs368814855	chr19:42082695-42082696	Weak transcription Flanking Active TSS Enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS	n/a	n/a	Overlapped CNVs	n/a
21	rs201728427	chr19:42082701-42082702	Weak transcription Flanking Active TSS Enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS	n/a	n/a	Overlapped CNVs	n/a
22	rs185182839	chr19:42082716-42082717	Weak transcription Flanking Active TSS Enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS	n/a	n/a	Overlapped CNVs	n/a
23	rs576873064	chr19:42082742-42082743	Weak transcription Flanking Active TSS Enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS	n/a	n/a	Overlapped CNVs	n/a
24	rs534610630	chr19:42082747-42082748	Weak transcription Flanking Active TSS Enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS	n/a	n/a	Overlapped CNVs	n/a
25	rs554395278	chr19:42082751-42082752	Weak transcription Flanking Active TSS Enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS	n/a	n/a	Overlapped CNVs	n/a
26	rs572643462	chr19:42082762-42082763	Weak transcription Flanking Active TSS Enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS	n/a	n/a	Overlapped CNVs	n/a
27	rs547080026	chr19:42082777-42082778	Weak transcription Flanking Active TSS Enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS	n/a	n/a	Overlapped CNVs	n/a
28	rs116010471	chr19:42082815-42082816	Weak transcription Flanking Active TSS Enhancers Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
29	rs189654771	chr19:42082858-42082859	Weak transcription Flanking Active TSS Enhancers Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
30	rs145016580	chr19:42082881-42082882	Weak transcription Flanking Active TSS Enhancers Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
31	rs543479353	chr19:42082966-42082967	Weak transcription Flanking Active TSS Enhancers Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
32	rs565050902	chr19:42082989-42082990	Weak transcription Flanking Active TSS Enhancers Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
33	rs536287212	chr19:42082995-42082996	Weak transcription Flanking Active TSS Enhancers Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
34	rs554537717	chr19:42083009-42083010	Weak transcription Flanking Active TSS Enhancers Active TSS Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
35	rs181497960	chr19:42083040-42083041	Weak transcription Flanking Active TSS Enhancers Active TSS Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
36	rs36035116	chr19:42083047-42083048	Weak transcription Flanking Active TSS Enhancers Active TSS Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
37	rs541064550	chr19:42083050-42083051	Weak transcription Flanking Active TSS Enhancers Active TSS Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
38	rs559740205	chr19:42083051-42083052	Weak transcription Flanking Active TSS Enhancers Active TSS Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
39	rs374318418	chr19:42083058-42083059	Weak transcription Flanking Active TSS Enhancers Active TSS Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
40	rs548491052	chr19:42083065-42083066	Weak transcription Flanking Active TSS Enhancers Active TSS Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
41	rs377719916	chr19:42083119-42083120	Weak transcription Flanking Active TSS Enhancers Active TSS Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
42	rs569837664	chr19:42083134-42083135	Weak transcription Flanking Active TSS Enhancers Active TSS Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
43	rs117416787	chr19:42083152-42083153	Weak transcription Flanking Active TSS Enhancers Active TSS Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
44	rs536252024	chr19:42083196-42083197	Weak transcription Flanking Active TSS Enhancers Active TSS Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
45	rs570563097	chr19:42083198-42083199	Weak transcription Flanking Active TSS Enhancers Active TSS Bivalent/Poised TSS	n/a	n/a	Overlapped CNVs	n/a
46	rs184732556	chr19:42083236-42083237	Weak transcription Enhancers Flanking Active TSS Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
47	rs552682438	chr19:42083274-42083275	Weak transcription Enhancers Flanking Active TSS Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
48	rs568080152	chr19:42083306-42083307	Weak transcription Enhancers Flanking Active TSS Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
49	rs77705252	chr19:42083325-42083326	Weak transcription Enhancers Flanking Active TSS Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
50	rs558976939	chr19:42083356-42083357	Weak transcription Enhancers Flanking Active TSS Genic enhancers	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:64)

Disease	PMID	Source
Myelodysplastic syndrome	17634407	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Chordoma	21602918	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Cancer	21637783	CNVD
Retinoblastoma	21504564	CNVD
Medulloblastoma	21979893	CNVD
Ovarian cancer	21720365	CNVD
Cancer	20164919	CNVD
Thoracic aortic aneurysm	21092924	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Prostate cancer	18632612	CNVD
Autism	22495311	CNVD
Adenoid cystic carcinoma	18698036	CNVD
Ductal carcinoma	22052326	CNVD
Congenital nephrotic syndrome	18421352	CNVD
Astrocytoma	17934521	CNVD
Leukemia	17361228	CNVD
Adenoid cystic carcinoma	17372589	CNVD
Breast cancer	21858162	CNVD
Breast cancer	17603634	CNVD
Glioma	21971842	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Endometrial cancer	22040021	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Oligodendroglial tumors	17285580	CNVD
renal disease	20603712	CNVD
Salivary gland adenoid cystic carcinoma	17545515	CNVD
Ovarian cancer	22174824	CNVD
Breast cancer	16608533	CNVD
Neuroblastoma	18923191	CNVD
Breast cancer	21364760	CNVD
Invasive pancreatic ductal carcinoma	18765526	CNVD
Rhabdomyosarcoma	16790082	CNVD
Chordoma	18071362	CNVD
Urothelial carcinoma	21177765	CNVD
small cell lung cancer	20016488	CNVD
Wilms tumour	21544195	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Ovarian neoplasms	16753589	CNVD
Malignant fibrous histiocytomas	21085701	CNVD
Metanephric adenoma	20802469	CNVD
Acute myeloid leukemia	16864856	CNVD
Bladder cancer	21909424	CNVD
Medulloblastoma	16783165	CNVD
Gastric cancer	18160780	CNVD
Hepatocellular carcinoma	16750200	CNVD
Basal cell lymphoma	19029149	CNVD
Breast cancer	20409316	CNVD
Diffuse large b-cell lymphoma	19029149	CNVD
Multiple myeloma	16616336	CNVD
Renal cell carcinoma	18765545	CNVD
Acute myeloid leukemia	20729466	CNVD
Lung cancer	18438408	CNVD
Genital abnormality	22378287	CNVD
Hypospadia	22378287	CNVD
Ovarian clear cell carcinoma	19293255	CNVD
Astrocytoma	22246337	CNVD
Schizophrenia	18511947	CNVD
Melanoma	20877625	CNVD
Breast cancer	22522925	CNVD

Chromatin state (count:227 , 50 per page) page: 1 2 3 4 5

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr19:42081600-42083000	Enhancers	Primary T helper memory cells from peripheral blood 1	blood
2	chr19:42081800-42082400	Enhancers	Primary monocytes fromperipheralblood	blood
3	chr19:42081800-42082400	Enhancers	Primary B cells from cord blood	blood
4	chr19:42081800-42082400	Enhancers	Primary T cells from cord blood	blood
5	chr19:42081800-42082400	Enhancers	Primary T cells fromperipheralblood	blood
6	chr19:42081800-42082400	Enhancers	Primary hematopoietic stem cells short term culture	blood
7	chr19:42081800-42082400	Enhancers	Primary T helper memory cells from peripheral blood 2	blood
8	chr19:42081800-42082400	Enhancers	Primary T helper naive cells fromperipheralblood	blood
9	chr19:42081800-42082400	Enhancers	Primary T helper cells fromperipheralblood	blood
10	chr19:42081800-42082400	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
11	chr19:42081800-42082600	Enhancers	Primary B cells from peripheral blood	blood
12	chr19:42081800-42082600	Enhancers	Primary Natural Killer cells fromperipheralblood	blood
13	chr19:42081800-42082600	Bivalent Enhancer	Fetal Muscle Trunk	muscle
14	chr19:42081800-42082800	Enhancers	Left Ventricle	heart
15	chr19:42081800-42083200	Enhancers	Primary T killer memory cells from peripheral blood	blood
16	chr19:42082000-42082600	Enhancers	Primary hematopoietic stem cells	blood
17	chr19:42082000-42082600	Enhancers	Esophagus	oesophagus
18	chr19:42082000-42082600	Bivalent Enhancer	Fetal Adrenal Gland	Adrenal Gland
19	chr19:42082000-42082800	Enhancers	Lung	lung
20	chr19:42082000-42082800	Enhancers	Right Ventricle	heart
21	chr19:42082000-42083200	Enhancers	Thymus	Thymus
22	chr19:42082000-42083800	Enhancers	Primary T killer naive cells fromperipheralblood	blood
23	chr19:42082000-42084000	Flanking Active TSS	Monocytes-CD14+_RO01746	blood
24	chr19:42082200-42082400	Flanking Bivalent TSS/Enh	Adipose Nuclei	Adipose
25	chr19:42082200-42082400	Flanking Active TSS	Duodenum Mucosa	Duodenum
26	chr19:42082200-42082400	Enhancers	Fetal Thymus	thymus
27	chr19:42082200-42082400	Bivalent Enhancer	Rectal Mucosa Donor 31	rectum
28	chr19:42082200-42082600	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
29	chr19:42082200-42082600	Enhancers	Primary mononuclear cells fromperipheralblood	Blood
30	chr19:42082200-42082600	Enhancers	Fetal Muscle Leg	muscle
31	chr19:42082200-42082600	Flanking Active TSS	Spleen	Spleen
32	chr19:42082200-42082800	Flanking Active TSS	Primary T helper naive cells from peripheral blood	blood
33	chr19:42082200-42082800	Flanking Active TSS	Primary T helper cells PMA-I stimulated	--
34	chr19:42082200-42082800	Flanking Active TSS	Primary T helper 17 cells PMA-I stimulated	--
35	chr19:42082200-42082800	Flanking Active TSS	Primary T cells effector/memory enriched fromperipheralblood	blood
36	chr19:42082200-42082800	Enhancers	Right Atrium	heart
37	chr19:42082200-42082800	Active TSS	Skeletal Muscle Female	skeletal muscle
38	chr19:42082200-42083000	Flanking Active TSS	Primary T regulatory cells fromperipheralblood	blood
39	chr19:42082200-42083000	Flanking Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Male	--
40	chr19:42082200-42083000	Flanking Active TSS	GM12878-XiMat	blood
41	chr19:42082200-42085200	Flanking Active TSS	Primary neutrophils fromperipheralblood	blood
42	chr19:42082400-42082600	Bivalent Enhancer	Adipose Nuclei	Adipose
43	chr19:42082400-42082600	Bivalent/Poised TSS	Rectal Mucosa Donor 31	rectum
44	chr19:42082400-42082600	Bivalent Enhancer	HUVEC	blood vessel
45	chr19:42082400-42082800	Flanking Active TSS	Primary T cells fromperipheralblood	blood
46	chr19:42082400-42082800	Flanking Active TSS	Primary T helper memory cells from peripheral blood 2	blood
47	chr19:42082400-42082800	Flanking Active TSS	Primary T helper cells fromperipheralblood	blood
48	chr19:42082400-42082800	Flanking Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Female	--
49	chr19:42082400-42082800	Enhancers	Duodenum Mucosa	Duodenum
50	chr19:42082400-42082800	Flanking Active TSS	Fetal Thymus	thymus

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links